Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor BKM120 in recurrent glioblastoma (GBM) Meeting Abstract
| Authors: | Wen, P. Y.; Yung, W. K. A.; Mellinghoff, I. K.; Lamborn, K.; Ramkissoon, S.; Cloughesy, T. F.; Rinne, M.; Omuro, A. M. P.; DeAngelis, L. M.; Gilbert, M. R.; Chi, A. S.; Batchelor, T.; Colman, H.; Chang, S. M.; Massacesi, C.; DiTomaso, E.; Prados, M.; Reardon, D. A.; Ligon, K. L. |
| Abstract Title: | Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor BKM120 in recurrent glioblastoma (GBM) |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419600676 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.2015 |
| Notes: | Meeting Abstract: 2015 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
271Mellinghoff -
576De Angelis -
204Omuro
Related MSK Work